Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children’s Oncology Group protocol AAML0531

Diagnostic biomarkers can be used to determine relapse risk in acute myeloid leukemia, and certain genetic aberrancies have prognostic relevance. A diagnostic immunophenotypic expression profile, which quantifies the amounts of distinct gene products, not just their presence or absence, was establis...

Descripción completa

Detalles Bibliográficos
Autores principales: Voigt, Andrew P., Brodersen, Lisa Eidenschink, Alonzo, Todd A., Gerbing, Robert B., Menssen, Andrew J., Wilson, Elisabeth R., Kahwash, Samir, Raimondi, Susana C., Hirsch, Betsy A., Gamis, Alan S., Meshinchi, Soheil, Wells, Denise A., Loken, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709105/
https://www.ncbi.nlm.nih.gov/pubmed/28883080
http://dx.doi.org/10.3324/haematol.2017.169029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709105/
https://www.ncbi.nlm.nih.gov/pubmed/28883080
http://dx.doi.org/10.3324/haematol.2017.169029

Ejemplares similares